Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV

• Autors principals: Enkosi Mondleki (Autor), Clifford G. Banda (Autor), Nomathemba C. Chandiwana (Autor), Simiso Sokhela (Autor), Lubbe Wiesner (Autor), Francois Venter (Autor), Gary Maartens (Autor), Phumla Z. Sinxadi (Autor)
• Format: Llibre
• Publicat: AOSIS, 2022-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Dolutegravir, a component of the preferred first-line antiretroviral therapy regimen, has been associated with increased weight gain. South Africa has a high prevalence of obesity, especially among women. Understanding dolutegravir exposure in patients with obesity is important for dose...